Annual CFO
-$46.42 M
+$6.04 M+11.52%
December 31, 2023
Summary
- As of February 23, 2025, MIST annual cash flow from operations is -$46.42 million, with the most recent change of +$6.04 million (+11.52%) on December 31, 2023.
- During the last 3 years, MIST annual CFO has risen by +$4.31 million (+8.49%).
- MIST annual CFO is now -476.55% below its all-time high of -$8.05 million, reached on December 31, 2017.
Performance
MIST Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$7.02 M
-$965.00 K-15.94%
September 30, 2024
Summary
- As of February 23, 2025, MIST quarterly cash flow from operations is -$7.02 million, with the most recent change of -$965.00 thousand (-15.94%) on September 30, 2024.
- Over the past year, MIST quarterly CFO has stayed the same.
- MIST quarterly CFO is now -791.43% below its all-time high of $1.01 million, reached on June 30, 2021.
Performance
MIST Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$31.80 M
+$5.14 M+13.92%
September 30, 2024
Summary
- As of February 23, 2025, MIST TTM cash flow from operations is -$31.80 million, with the most recent change of +$5.14 million (+13.92%) on September 30, 2024.
- Over the past year, MIST TTM CFO has stayed the same.
- MIST TTM CFO is now -573.32% below its all-time high of -$4.72 million, reached on March 31, 2018.
Performance
MIST TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
MIST Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +11.5% | 0.0% | 0.0% |
| 3 y3 years | +8.5% | 0.0% | 0.0% |
| 5 y5 years | -120.6% | 0.0% | 0.0% |
MIST Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -39.7% | +11.5% | -15.9% | +50.2% | at high | +39.4% |
| 5 y | 5-year | -39.7% | +11.5% | -791.4% | +61.2% | -15.4% | +46.6% |
| alltime | all time | -476.6% | +11.5% | -791.4% | +61.2% | -573.3% | +46.6% |
Milestone Pharmaceuticals Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.02 M(+15.9%) | -$31.80 M(-13.9%) |
| Jun 2024 | - | -$6.05 M(-32.2%) | -$36.94 M(-10.9%) |
| Mar 2024 | - | -$8.93 M(-8.8%) | -$41.45 M(-10.7%) |
| Dec 2023 | -$46.42 M(-11.5%) | -$9.80 M(-19.4%) | -$46.42 M(-6.2%) |
| Sep 2023 | - | -$12.16 M(+15.1%) | -$49.49 M(+1.2%) |
| Jun 2023 | - | -$10.56 M(-24.0%) | -$48.90 M(-6.7%) |
| Mar 2023 | - | -$13.90 M(+8.1%) | -$52.42 M(-0.1%) |
| Dec 2022 | -$52.47 M(+57.9%) | -$12.86 M(+11.1%) | -$52.47 M(+0.9%) |
| Sep 2022 | - | -$11.57 M(-17.8%) | -$51.98 M(+4.4%) |
| Jun 2022 | - | -$14.09 M(+1.0%) | -$49.80 M(+43.5%) |
| Mar 2022 | - | -$13.95 M(+12.7%) | -$34.70 M(+4.5%) |
| Dec 2021 | -$33.22 M | -$12.38 M(+31.8%) | -$33.22 M(+12.2%) |
| Sep 2021 | - | -$9.39 M(-1025.3%) | -$29.60 M(+7.5%) |
| Jun 2021 | - | $1.01 M(-108.1%) | -$27.55 M(-39.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$12.47 M(+42.4%) | -$45.12 M(-11.1%) |
| Dec 2020 | -$50.73 M(-0.8%) | -$8.76 M(+19.4%) | -$50.73 M(-13.4%) |
| Sep 2020 | - | -$7.33 M(-55.7%) | -$58.58 M(-1.6%) |
| Jun 2020 | - | -$16.56 M(-8.4%) | -$59.54 M(+9.3%) |
| Mar 2020 | - | -$18.08 M(+8.9%) | -$54.50 M(+6.5%) |
| Dec 2019 | -$51.15 M(+143.0%) | -$16.60 M(+100.1%) | -$51.15 M(+22.2%) |
| Sep 2019 | - | -$8.30 M(-28.0%) | -$41.86 M(+6.9%) |
| Jun 2019 | - | -$11.52 M(-21.8%) | -$39.15 M(+26.1%) |
| Mar 2019 | - | -$14.73 M(+101.5%) | -$31.06 M(+47.6%) |
| Dec 2018 | -$21.05 M(+161.4%) | -$7.31 M(+30.8%) | -$21.05 M(+53.2%) |
| Sep 2018 | - | -$5.59 M(+63.4%) | -$13.73 M(+68.7%) |
| Jun 2018 | - | -$3.42 M(-27.6%) | -$8.14 M(+72.4%) |
| Mar 2018 | - | -$4.72 M | -$4.72 M |
| Dec 2017 | -$8.05 M | - | - |
FAQ
- What is Milestone Pharmaceuticals annual cash flow from operations?
- What is the all time high annual CFO for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals annual CFO year-on-year change?
- What is Milestone Pharmaceuticals quarterly cash flow from operations?
- What is the all time high quarterly CFO for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals quarterly CFO year-on-year change?
- What is Milestone Pharmaceuticals TTM cash flow from operations?
- What is the all time high TTM CFO for Milestone Pharmaceuticals?
- What is Milestone Pharmaceuticals TTM CFO year-on-year change?
What is Milestone Pharmaceuticals annual cash flow from operations?
The current annual CFO of MIST is -$46.42 M
What is the all time high annual CFO for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high annual cash flow from operations is -$8.05 M
What is Milestone Pharmaceuticals annual CFO year-on-year change?
Over the past year, MIST annual cash flow from operations has changed by +$6.04 M (+11.52%)
What is Milestone Pharmaceuticals quarterly cash flow from operations?
The current quarterly CFO of MIST is -$7.02 M
What is the all time high quarterly CFO for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high quarterly cash flow from operations is $1.01 M
What is Milestone Pharmaceuticals quarterly CFO year-on-year change?
Over the past year, MIST quarterly cash flow from operations has changed by $0.00 (0.00%)
What is Milestone Pharmaceuticals TTM cash flow from operations?
The current TTM CFO of MIST is -$31.80 M
What is the all time high TTM CFO for Milestone Pharmaceuticals?
Milestone Pharmaceuticals all-time high TTM cash flow from operations is -$4.72 M
What is Milestone Pharmaceuticals TTM CFO year-on-year change?
Over the past year, MIST TTM cash flow from operations has changed by $0.00 (0.00%)